Does simultaneous determination of LDL and HDL particle size improve prediction of coronary artery disease risk?
Само за регистроване кориснике
2008
Аутори
Zeljković, AleksandraSpasojević-Kalimanovska, Vesna
Vekić, Jelena
Jelić-Ivanović, Zorana
Topić, Aleksandra
Bogavac-Stanojević, Nataša
Spasić, Slavica
Vujović, Ana
Kalimanovska-Oštrić, Dimitra
Чланак у часопису (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
Background Alterations in plasma lipoprotein subclass distribution affect the risk for coronary artery disease (CAD). However, it is unclear whether the determination of low-density lipoprotein (LDL) and high-density lipoprotein (HDL) phenotypes may or may not improve the ability to predict CAD development. Methods Polyacrylamide gradient (3-31%) gel electrophoresis was used to simultaneously determine size and distribution of lipoprotein subclasses in 181 CAD patients and 178 controls. Results Mean LDL and HDL subclass sizes were significantly smaller in patients than in controls (p lt 0.001). Multivariate logistic regression analysis showed that small dense LDL particles were independent CAD risk predictors (OR = 2.867, p lt 0.01), even when adjusted for other traditional risk factors, while small HDL particles lost their significance after adjustment (OR = 2.071, p = 0.054). The area under the ROC curve for LDL (0.671) and HDL (0.643) particle size measurement demonstrated low c...linical accuracy when compared to the combination of traditional lipid risk factor measurements. Conclusions CAD is associated with the predominance of smaller LDL and HDL particles. However, simultaneous determination of these two lipoprotein phenotypes provides no additional power in discriminating CAD and non-CAD subjects, beyond that obtained by the traditional risk factors.
Кључне речи:
lipoprotein subclasses / CAD risk predictionИзвор:
Clinical and Experimental Medicine, 2008, 8, 2, 109-116Издавач:
- Springer, New York
Финансирање / пројекти:
- Испитивање биохемијских и генетичких фактора ризика као узрочника и маркера атеросклерозе и других обољења: аналитички и клинички аспекти (RS-MESTD-MPN2006-2010-145036)
DOI: 10.1007/s10238-008-0165-z
ISSN: 1591-8890
PubMed: 18618221
WoS: 000257022600008
Scopus: 2-s2.0-47349124839
Институција/група
PharmacyTY - JOUR AU - Zeljković, Aleksandra AU - Spasojević-Kalimanovska, Vesna AU - Vekić, Jelena AU - Jelić-Ivanović, Zorana AU - Topić, Aleksandra AU - Bogavac-Stanojević, Nataša AU - Spasić, Slavica AU - Vujović, Ana AU - Kalimanovska-Oštrić, Dimitra PY - 2008 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1082 AB - Background Alterations in plasma lipoprotein subclass distribution affect the risk for coronary artery disease (CAD). However, it is unclear whether the determination of low-density lipoprotein (LDL) and high-density lipoprotein (HDL) phenotypes may or may not improve the ability to predict CAD development. Methods Polyacrylamide gradient (3-31%) gel electrophoresis was used to simultaneously determine size and distribution of lipoprotein subclasses in 181 CAD patients and 178 controls. Results Mean LDL and HDL subclass sizes were significantly smaller in patients than in controls (p lt 0.001). Multivariate logistic regression analysis showed that small dense LDL particles were independent CAD risk predictors (OR = 2.867, p lt 0.01), even when adjusted for other traditional risk factors, while small HDL particles lost their significance after adjustment (OR = 2.071, p = 0.054). The area under the ROC curve for LDL (0.671) and HDL (0.643) particle size measurement demonstrated low clinical accuracy when compared to the combination of traditional lipid risk factor measurements. Conclusions CAD is associated with the predominance of smaller LDL and HDL particles. However, simultaneous determination of these two lipoprotein phenotypes provides no additional power in discriminating CAD and non-CAD subjects, beyond that obtained by the traditional risk factors. PB - Springer, New York T2 - Clinical and Experimental Medicine T1 - Does simultaneous determination of LDL and HDL particle size improve prediction of coronary artery disease risk? VL - 8 IS - 2 SP - 109 EP - 116 DO - 10.1007/s10238-008-0165-z ER -
@article{ author = "Zeljković, Aleksandra and Spasojević-Kalimanovska, Vesna and Vekić, Jelena and Jelić-Ivanović, Zorana and Topić, Aleksandra and Bogavac-Stanojević, Nataša and Spasić, Slavica and Vujović, Ana and Kalimanovska-Oštrić, Dimitra", year = "2008", abstract = "Background Alterations in plasma lipoprotein subclass distribution affect the risk for coronary artery disease (CAD). However, it is unclear whether the determination of low-density lipoprotein (LDL) and high-density lipoprotein (HDL) phenotypes may or may not improve the ability to predict CAD development. Methods Polyacrylamide gradient (3-31%) gel electrophoresis was used to simultaneously determine size and distribution of lipoprotein subclasses in 181 CAD patients and 178 controls. Results Mean LDL and HDL subclass sizes were significantly smaller in patients than in controls (p lt 0.001). Multivariate logistic regression analysis showed that small dense LDL particles were independent CAD risk predictors (OR = 2.867, p lt 0.01), even when adjusted for other traditional risk factors, while small HDL particles lost their significance after adjustment (OR = 2.071, p = 0.054). The area under the ROC curve for LDL (0.671) and HDL (0.643) particle size measurement demonstrated low clinical accuracy when compared to the combination of traditional lipid risk factor measurements. Conclusions CAD is associated with the predominance of smaller LDL and HDL particles. However, simultaneous determination of these two lipoprotein phenotypes provides no additional power in discriminating CAD and non-CAD subjects, beyond that obtained by the traditional risk factors.", publisher = "Springer, New York", journal = "Clinical and Experimental Medicine", title = "Does simultaneous determination of LDL and HDL particle size improve prediction of coronary artery disease risk?", volume = "8", number = "2", pages = "109-116", doi = "10.1007/s10238-008-0165-z" }
Zeljković, A., Spasojević-Kalimanovska, V., Vekić, J., Jelić-Ivanović, Z., Topić, A., Bogavac-Stanojević, N., Spasić, S., Vujović, A.,& Kalimanovska-Oštrić, D.. (2008). Does simultaneous determination of LDL and HDL particle size improve prediction of coronary artery disease risk?. in Clinical and Experimental Medicine Springer, New York., 8(2), 109-116. https://doi.org/10.1007/s10238-008-0165-z
Zeljković A, Spasojević-Kalimanovska V, Vekić J, Jelić-Ivanović Z, Topić A, Bogavac-Stanojević N, Spasić S, Vujović A, Kalimanovska-Oštrić D. Does simultaneous determination of LDL and HDL particle size improve prediction of coronary artery disease risk?. in Clinical and Experimental Medicine. 2008;8(2):109-116. doi:10.1007/s10238-008-0165-z .
Zeljković, Aleksandra, Spasojević-Kalimanovska, Vesna, Vekić, Jelena, Jelić-Ivanović, Zorana, Topić, Aleksandra, Bogavac-Stanojević, Nataša, Spasić, Slavica, Vujović, Ana, Kalimanovska-Oštrić, Dimitra, "Does simultaneous determination of LDL and HDL particle size improve prediction of coronary artery disease risk?" in Clinical and Experimental Medicine, 8, no. 2 (2008):109-116, https://doi.org/10.1007/s10238-008-0165-z . .